SPRC (S-Propargyl-cysteine) has been shown to attenuate spatial learning and memory deficits via the TNF signaling and NF-κB signaling pathways in a rat model induced by lipopolysaccharide 51, but further studies are needed to elucidate the relationship between TRAF1 and AD. Here, TRAF1 is linked to Alzheimer disease.